Cerenome (CNSY) Stock Price, News & Analysis
Ticker history: PSTV became CNSY (Cerenome, Inc.) on . Earlier news and filings retain their original names and dates. View PSTV history.
What Changed
Price Move History
- Daily moves over 5%
- 88 252 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- -38.3% close of January 14, 2026
- 1-year change
- -95% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- -57.1% closing prices, October 5, 2026 to November 5, 2026
Company Description
Cerenome (NASDAQ: CNSY) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $5.3M.
CNSY has declined 95.0% over the past year. The last closing price was $0.6699.
For FY2025, Cerenome reported revenue of $5.2M with net income of -$22.4M and diluted earnings per share of -$0.29.
This page collects what Stock Titan holds for CNSY, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cerenome (CNSY) closed at $0.6699 on November 5, 2026. Over the past 12 months, the price has lost 95.0%.
CNSY Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Cerenome has 10 recent news articles, with the latest published yesterday. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial. View all CNSY news →
SEC Filings
Cerenome has filed 10 recent SEC filings, including 7 Form 4, 2 Form 8-K, 1 Form D. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNSY SEC filings →
Financial Highlights
Cerenome generated $5.2M in revenue in FY2025, operating income reached -$15.3M, and net income was -$22.4M. Diluted earnings per share stood at -$0.29. The company generated -$20.8M in operating cash flow. The current ratio was 1.23, measuring current assets divided by current liabilities.
Upcoming Events
Poster presentation
Company symposium
Phase 2 study start
Medicare pricing effective
Covered lives target
Topline data release
FDA meeting
Cerenome has 7 upcoming scheduled events. The next event, "Poster presentation", is scheduled for November 13, 2026 (in 8 days). Investors can track these dates to stay informed about potential catalysts that may affect the CNSY stock price.
Short Interest History
Short interest in Cerenome (CNSY) currently stands at 782.1 thousand shares, up 4.4% from the previous reporting period, representing 10.5% of the float. Since August 2026, short interest has increased by 25.2%.
Days to Cover History
Days to cover for Cerenome (CNSY) currently stands at 3.5 days, down 39.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has decreased by 54.7%. Across the settlements charted above, it has ranged from 3.5 to 8.7 days.
CNSY Company Profile & Sector Positioning
Cerenome (CNSY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CNSY often look at related companies in the same sector, including FibroBiologics, Inc. (FBLG), Immuron Limited (IMRN), Senti Biosciences Holdings, Inc. (SNTI), Enveric Biosciences, Inc. (ENVB), and Exicure, Inc. (XCUR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNSY's relative position within its industry.